RECRUITING

Effect of Music on Cue Reactivity for Patients With Opioid Use Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research is being performed to understand the role of music in people's opioid cravings, opioid use, and recovery. Music affects individuals in so many ways, and can trigger strong good and bad emotions. People listen when they are sad and want to feel happy, when they are with friends, when they exercise, and when they just want to pass the time. However, it is not known what role music plays in adding to or taking away cravings, and the role it has in drug use and addiction. In this study, the researchers want to learn if music can reduce cues that lead to cravings for opioids. The researchers also want to learn about subjects' relationship to music and how it contributes to drug use, recovery, and their life overall.

Official Title

Effect of Music on Cue Reactivity for Patients With Opioid Use Disorder

Quick Facts

Study Start:2025-04-20
Study Completion:2027-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06948890

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults aged 18 years or older
  2. * Current diagnosis of opioid use disorder
  3. * Actively receiving buprenorphine or methadone treatment with a stable dose of at least 30 days
  1. * Any significant impairment in mental status that would interfere with the ability to provided informed consent including suicidality, homicidality, or psychosis.
  2. * Hearing impaired
  3. * Vision impaired
  4. * Patient reports that they are pregnant
  5. * Requiring the use of any prescription opioid analgesics during the trial
  6. * Currently prescribed naltrexone
  7. * Chronic pain, defined as pain on the numeric rating scale (0-10) of \>3 every day for over 3 months.

Contacts and Locations

Study Contact

Scott G Weiner, MD, MPH
CONTACT
617-732-5640
sweiner@bwh.harvard.edu

Principal Investigator

Scott G Weiner, MD, MPH
PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital

Study Locations (Sites)

Brigham and Women's Hospital
Boston, Massachusetts, 02459
United States

Collaborators and Investigators

Sponsor: Brigham and Women's Hospital

  • Scott G Weiner, MD, MPH, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-20
Study Completion Date2027-12-31

Study Record Updates

Study Start Date2025-04-20
Study Completion Date2027-12-31

Terms related to this study

Keywords Provided by Researchers

  • opioid
  • opioid use disorder
  • methadone
  • buprenorphine
  • music
  • cue reactivity

Additional Relevant MeSH Terms

  • Opioid Use Disorder